What to know about anti-Chlamydia trachomatis

Chlamydia trachomatis is a bacterium that can cause a sexually transmitted infection. An antibody result reflects the immune system’s response and does not, by itself, establish whether infection is currently active. Testing a urine sample or a swab for bacterial genetic material is commonly used when current genital infection is suspected. The wording on the laboratory report and the sample type are therefore essential for interpretation.

Chlamydia may cause no noticeable symptoms. When symptoms occur, they can include painful urination, altered vaginal discharge, bleeding between periods, pelvic discomfort, or discharge from the penis. Chlamydia can present with these symptoms, but each symptom also has other possible causes.

Check whether the report says antibody, antigen, PCR, NAAT, urine, or swab, and take the complete report to a clinician or sexual-health service. If active infection is confirmed, take the prescribed antibiotic exactly as directed and do not share leftover medicine. A clinician can advise when sexual contact can resume, whether recent partners should be notified and tested, and whether repeat testing is appropriate.

Until you receive specific advice, avoid sexual contact if you have a positive result or symptoms that could represent an infection. Barrier protection reduces transmission risk but does not replace assessment and appropriate treatment.

Arrange prompt medical assessment for a positive test, a partner’s confirmed diagnosis, painful urination, unusual genital discharge, or bleeding between periods. Seek urgent care for severe or worsening lower-abdominal pain, fainting, persistent vomiting, heavy bleeding, fever with pelvic pain, or testicular pain or swelling. Pelvic inflammatory disease can present with pelvic pain, abnormal bleeding, discharge, pain during sex, or fever and needs timely evaluation.

Ask what the test actually detected, whether it indicates a current infection, which antibiotic is appropriate, and what to do if a dose is missed or vomiting occurs. Also ask which body sites were tested, whether other STI screening is suitable, when partners should be contacted, and which symptoms should trigger urgent reassessment.